{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prophylaxis+C&page=4", "query": { "intervention": "Prophylaxis C", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 330, "total_pages": 33, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prophylaxis+C&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Prophylaxis+C&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T01:20:50.004Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06500884", "title": "A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Talquetamab", "type": "DRUG" }, { "name": "Prophylaxis A", "type": "DRUG" }, { "name": "Prophylaxis B", "type": "DRUG" }, { "name": "Prophylaxis C", "type": "DRUG" }, { "name": "Prophylaxis D", "type": "DRUG" }, { "name": "Ramantamig", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 210, "start_date": "2024-08-26", "completion_date": "2030-05-30", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 9, "location_summary": "San Francisco, California • Denver, Colorado • New Haven, Connecticut + 6 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "New York", "state": "New York" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06500884" }, { "nct_id": "NCT05929521", "title": "Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Sex Work", "Pre-Exposure Prophylaxis" ], "interventions": [ { "name": "C-PrEP+", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Illinois at Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2024-12-12", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2025-09-22", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05929521" }, { "nct_id": "NCT04592198", "title": "Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Nausea With Vomiting Chemotherapy-Induced" ], "interventions": [ { "name": "Palonosetron Hydrochloride Buccal Film 0.25 Mg", "type": "DRUG" }, { "name": "Palonosetron Hydrochloride Buccal Film 0.5 Mg", "type": "DRUG" }, { "name": "Palonosetron Hydrochloride, 0.25 Mg/5 mL Intravenous Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Xiamen LP Pharmaceutical Co., Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2020-10-01", "completion_date": "2021-03-25", "has_results": true, "last_update_posted_date": "2025-03-24", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 7, "location_summary": "Anaheim, California • Ocala, Florida • Skokie, Illinois + 4 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Ocala", "state": "Florida" }, { "city": "Skokie", "state": "Illinois" }, { "city": "Hattiesburg", "state": "Mississippi" }, { "city": "Gettysburg", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04592198" }, { "nct_id": "NCT04626947", "title": "Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Inflammatory Bowel Diseases", "Ulcerative Colitis", "Crohn Disease", "C. Diff. Infections" ], "interventions": [ { "name": "Bezlotoxumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "David Binion, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2021-10-14", "completion_date": "2024-05-31", "has_results": true, "last_update_posted_date": "2025-06-05", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04626947" }, { "nct_id": "NCT00464009", "title": "Development and Evaluation of a Medical Intervention for Early Childhood Caries", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Early Childhood Dental Caries" ], "interventions": [ { "name": "Continuing medical education", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 120, "start_date": "2001-02", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2010-01-29", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00464009" }, { "nct_id": "NCT00685347", "title": "Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma", "Bronchoconstriction" ], "interventions": [ { "name": "Levalbuterol HFA MDI", "type": "DRUG" }, { "name": "Racemic Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 33, "start_date": "2003-01", "completion_date": "2003-06", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 6, "location_summary": "Long Beach, California • Denver, Colorado • Englewood, Colorado + 3 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Russells Mills", "state": "Massachusetts" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00685347" }, { "nct_id": "NCT03358836", "title": "Joint Health Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hemophilia B" ], "interventions": [], "intervention_types": [], "sponsor": "Bloodworks", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "MALE", "summary": "16 Years and older · Male only" }, "enrollment_count": 8, "start_date": "2017-11-15", "completion_date": "2020-08-17", "has_results": false, "last_update_posted_date": "2022-06-22", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 5, "location_summary": "Los Angeles, California • San Diego, California • New Orleans, Louisiana + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Portland", "state": "Oregon" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03358836" }, { "nct_id": "NCT07873944", "title": "Recovery Management Checkup Scalability and Sustainability Hybrid Experiment", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Substance Use Disorder (SUD)", "Opioid Use Disorders", "Stimulant Overdose", "Overdose Risk", "Alcohol Use Disorder" ], "interventions": [ { "name": "Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters)", "type": "BEHAVIORAL" }, { "name": "Recovery Management Checkups (RMC) delivered by staff under the research team (RMC by research staff)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Chestnut Health Systems", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2026-11-02", "completion_date": "2029-04-30", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07873944" }, { "nct_id": "NCT06098144", "title": "Smoking Cessation Program in the Construction Sector", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Smoking Cessation", "Tobacco Use Cessation", "Tobacco Smoking" ], "interventions": [ { "name": "Nicorette", "type": "DRUG" }, { "name": "Tobacco Quit-line", "type": "BEHAVIORAL" }, { "name": "Brief Behavioral Counseling", "type": "BEHAVIORAL" }, { "name": "Intensive Behavioral Counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 608, "start_date": "2024-04-10", "completion_date": "2027-07-28", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06098144" }, { "nct_id": "NCT03200093", "title": "Oral Vancomycin for Preventing Clostridium Difficile Recurrence", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Clostridium Difficile Infection" ], "interventions": [ { "name": "Oral Vancomycin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rochester General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2017-06-08", "completion_date": "2021-04-22", "has_results": false, "last_update_posted_date": "2021-04-26", "last_synced_at": "2026-10-25T01:20:50.004Z", "location_count": 1, "location_summary": "Rochester, New York", "locations": [ { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03200093" } ] }